MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$364,252K
Net Income
-$57,939K
Net Profit Margin
-15.91%
EPS
-$1.99
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenue, net
364,252
311,337
321,083
287,268
Cost of sales
40,007
26,847
24,448
18,122
Research and development
91,178
108,692
116,268
174,004
Selling, general and administrative
289,375
268,521
239,976
209,117
Total operating expenses
420,560
404,060
380,692
401,243
Loss from operations
-56,308
-92,723
-59,609
-113,975
Interest income
7,104
8,243
9,459
10,308
Interest expense
7,940
7,819
8,297
7,451
Gain on extinguishment of debt
-
-
-167*
-2,779
Other expense, net
-795
-2,092
40*
-293
Net loss
-57,939
-94,391
-58,575
-114,190
Basic EPS
-1.99
-3.25
-2.552
-5.08
Diluted EPS
-1.99
-3.25
-2.552
-5.08
Basic Average Shares
29,145,271
29,032,422
22,956,407
22,482,502
Diluted Average Shares
29,145,271
29,032,422
22,956,407
22,482,502
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$57,939K
(-37.03%↓ Y/Y)
Interest income
$7,104K
(-13.65%↓ Y/Y)
Loss from operations
-$56,308K
(-19.29%↓ Y/Y)
Interest expense
$7,940K
(143.26%↑ Y/Y)
Product revenue, net
$364,252K
(71.17%↑ Y/Y)
Other expense, net
-$795K
(-1792.86%↓ Y/Y)
Total operating
expenses
$420,560K
(61.75%↑ Y/Y)
Selling, general and
administrative
$289,375K
(47.00%↑ Y/Y)
Research and development
$91,178K
(68.60%↑ Y/Y)
Cost of sales
$40,007K
(341.33%↑ Y/Y)
Buy us a coffee
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)